DK0514415T3 - Drivgasblandinger og deres anvendelse i lægemiddelpræparater - Google Patents

Drivgasblandinger og deres anvendelse i lægemiddelpræparater

Info

Publication number
DK0514415T3
DK0514415T3 DK91903275T DK91903275T DK0514415T3 DK 0514415 T3 DK0514415 T3 DK 0514415T3 DK 91903275 T DK91903275 T DK 91903275T DK 91903275 T DK91903275 T DK 91903275T DK 0514415 T3 DK0514415 T3 DK 0514415T3
Authority
DK
Denmark
Prior art keywords
pref
alkane
pharmaceutical preparations
opt
surfactant
Prior art date
Application number
DK91903275T
Other languages
Danish (da)
English (en)
Inventor
Hans-Hermann Weil
Ottfried Daab
Original Assignee
Boehringer Ingelheim Pharma
Boehringer Ingelheim Kg
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6399400&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0514415(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Pharma, Boehringer Ingelheim Kg, Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Pharma
Application granted granted Critical
Publication of DK0514415T3 publication Critical patent/DK0514415T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Materials For Medical Uses (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
DK91903275T 1990-02-03 1991-01-31 Drivgasblandinger og deres anvendelse i lægemiddelpræparater DK0514415T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4003272A DE4003272A1 (de) 1990-02-03 1990-02-03 Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
PCT/EP1991/000177 WO1991011495A1 (de) 1990-02-03 1991-01-31 Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen

Publications (1)

Publication Number Publication Date
DK0514415T3 true DK0514415T3 (da) 1998-10-07

Family

ID=6399400

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91903275T DK0514415T3 (da) 1990-02-03 1991-01-31 Drivgasblandinger og deres anvendelse i lægemiddelpræparater

Country Status (24)

Country Link
US (1) US6413497B1 (ja)
EP (1) EP0514415B1 (ja)
JP (1) JP3497161B2 (ja)
AT (1) ATE165863T1 (ja)
AU (1) AU650001B2 (ja)
CA (1) CA2075058C (ja)
CZ (1) CZ286691B6 (ja)
DE (2) DE4003272A1 (ja)
DK (1) DK0514415T3 (ja)
ES (1) ES2117964T3 (ja)
FI (1) FI102905B (ja)
HK (1) HK1010786A1 (ja)
HR (1) HRP940735B1 (ja)
HU (2) HU218784B (ja)
IE (2) IE910351A1 (ja)
IL (1) IL97028A (ja)
NO (1) NO302419B1 (ja)
NZ (1) NZ236973A (ja)
PT (1) PT96634B (ja)
SI (1) SI9110156B (ja)
SK (1) SK280426B6 (ja)
WO (1) WO1991011495A1 (ja)
YU (1) YU49203B (ja)
ZA (1) ZA91754B (ja)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5776434A (en) 1988-12-06 1998-07-07 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
EP0536204B1 (en) * 1990-06-27 1994-04-06 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
ES2064160T3 (es) * 1990-10-18 1995-01-16 Minnesota Mining & Mfg Formulacion de aerosol que comprende 17,21-dipropionato de beclometasona.
MX9203481A (es) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
HU205249B (en) * 1990-11-09 1992-04-28 Egyt Gyogyszervegyeszeti Gyar Process for producing suspensive aerosole composition
GB9024366D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
US5725791A (en) * 1991-03-28 1998-03-10 E. I. Du Pont De Nemours And Company Azeotropic and azeotrope-like compositions of 1,1,2,2-tetrafluoroethane
US5182040A (en) * 1991-03-28 1993-01-26 E. I. Du Pont De Nemours And Company Azeotropic and azeotrope-like compositions of 1,1,2,2-tetrafluoroethane
EP0587790B2 (en) * 1991-06-10 2000-03-08 Schering Corporation Non-chlorofluorocarbon aerosol formulations
ES2158910T3 (es) * 1991-06-10 2001-09-16 Schering Corp Formulaciones en aerosol sin clorofluorocarbonos.
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
EP0616525B1 (en) * 1991-12-12 1995-09-27 Glaxo Group Limited Pharmaceutical aerosol formulation
CA2381329C (en) * 1991-12-12 2003-04-15 Glaxo Group Limited Medicaments
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US20030103907A1 (en) * 1991-12-18 2003-06-05 Schultz Robert K. Suspension aerosol formulations
DE69233319T2 (de) * 1991-12-18 2005-02-17 Minnesota Mining & Manufacturing Company, St. Paul Aerosolzusammensetzungen für Arzneimittelsuspensionen
DE4203306A1 (de) * 1992-02-06 1993-08-12 Ig Spruehtechnik Gmbh Asthma oder pulmonal-aerosolzubereitungen mit lecithin
WO1993022221A1 (en) * 1992-05-04 1993-11-11 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
DE4218291A1 (de) * 1992-06-03 1993-12-09 Mattern Et Partner Pharmazeuti Dosierspray für pernasale Applikation
US5833950A (en) * 1992-07-31 1998-11-10 Glaxo Group Limited Aerosol formulations containing beclomethasone dipropionate-1, 1, 1, 2-tetrafluoroethane solvate
WO1994004629A1 (en) * 1992-08-21 1994-03-03 E.I. Du Pont De Nemours And Company Substantially constant boiling mixtures of 1,1,1,2-tetrafluoroethane, dimethyl ether and isobutane
RU2126248C1 (ru) * 1992-12-09 1999-02-20 Берингер Ингельхейм Фармасьютикалз, Инк. Жидкая фармацевтическая композиция в форме аэрозоля
US5458798A (en) * 1993-02-05 1995-10-17 E. I. Du Pont De Nemours And Company Azeotropic and azeotrope-like compositions of a hydrofluorocarbon and a hydrocarbon
US5474758A (en) * 1993-07-28 1995-12-12 Minnesota Mining And Manufacturing Company Seals for use in an aerosol delivery device
EP0735884B1 (en) * 1993-12-20 2000-04-26 Minnesota Mining And Manufacturing Company Flunisolide aerosol formulations
CH686806A5 (de) * 1994-01-12 1996-06-28 Cerberus Ag Gasgemisch zur Funktionspruefung von Rauchmeldern.
US6001273A (en) 1994-03-11 1999-12-14 Minor; Barbara Haviland Binary azeotropes of difluoromethane and hydrocarbons
US5417871A (en) * 1994-03-11 1995-05-23 E. I. Du Pont De Nemours And Company Hydrofluorocarbon compositions
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
PL320856A1 (en) * 1994-12-22 1997-11-10 Astra Ab Aerosol drug preparations
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
US6013245A (en) * 1995-01-26 2000-01-11 Glaxo Group Limited Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
GB9507768D0 (en) 1995-04-13 1995-05-31 Glaxo Group Ltd Method of apparatus
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
GB9620187D0 (en) † 1996-09-27 1996-11-13 Minnesota Mining & Mfg Medicinal aerosol formulations
CA2280099C (en) 1997-02-05 2005-12-27 Jago Pharma Ag Medical aerosol formulations
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
GB9805938D0 (en) 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
ES2234266T3 (es) 1998-07-24 2005-06-16 Jago Research Ag Formulaciones medicas para aerosoles.
DE59904648D1 (de) * 1998-08-04 2003-04-24 Jago Res Ag Muttenz Medizinische aerosolformulierungen
US6458338B1 (en) * 1998-09-22 2002-10-01 Aeropharm Technology Incorporated Amino acid stabilized medicinal aerosol formulations
WO2002024623A2 (en) 2000-09-22 2002-03-28 Glaxo Group Limited Novel alkanoic acid derivatives
US20020193392A1 (en) * 2000-11-13 2002-12-19 Christel Schmelzer Pharmaceutical compositions based on tiotropium salts of salts of salmeterol
WO2002051483A1 (en) 2000-12-22 2002-07-04 Glaxo Group Limited Metered dose inhaler for salmeterol xinafoate
US20110301569A1 (en) 2001-01-20 2011-12-08 Gordon Wayne Dyer Methods and apparatus for the CVCS
US20030018019A1 (en) * 2001-06-23 2003-01-23 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions based on anticholinergics, corticosteroids and betamimetics
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
US6919325B2 (en) 2001-09-14 2005-07-19 Boehringer Ingelheim Pharma Kg Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
CN1633407A (zh) 2002-02-13 2005-06-29 葛兰素集团有限公司 用作表面活性剂的羧酸化合物
GB0205327D0 (en) 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
US7754242B2 (en) * 2002-03-20 2010-07-13 Alkermes, Inc. Inhalable sustained therapeutic formulations
US7279451B2 (en) * 2002-10-25 2007-10-09 Honeywell International Inc. Compositions containing fluorine substituted olefins
US20040152720A1 (en) * 2002-12-20 2004-08-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Powdered medicaments containing a tiotropium salt and salmeterol xinafoate
AU2004246819A1 (en) 2003-06-13 2004-12-23 Nycomed Gmbh Formoterol and ciclesonide combination
EP2275479A1 (en) 2003-08-11 2011-01-19 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
US20080190418A1 (en) 2003-08-29 2008-08-14 Glaxo Group Limited Pharmaceutical Metered Dose Inhaler and Methods Relating Thereto
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
AR041873A1 (es) * 2003-10-30 2005-06-01 Pablo Cassara Srl Lab Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
EP1744800B1 (en) 2004-04-21 2016-06-22 Innovata Biomed Limited Inhaler
PL2425820T3 (pl) 2007-02-11 2015-08-31 Map Pharmaceuticals Inc Sposób terapeutycznego stosowania dhe w celu umożliwienia szybkiego złagodzenia migreny przy jednoczesnym zminimalizowaniu profilu działań niepożądanych
US20110311475A1 (en) 2009-01-05 2011-12-22 Stephan Borte Means and method for the treatment of antibody deficiency diseases based on il-21 and il-21 variants
EP2504013A1 (en) 2009-11-24 2012-10-03 Gilead Sciences, Inc. Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease
WO2011081937A1 (en) 2009-12-15 2011-07-07 Gilead Sciences, Inc. Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
UY33372A (es) 2010-05-10 2011-12-30 Gilead Sciences Inc ?análogos de quinolina bi?funcionales, su uso en la manufactura de medicamentos,composiciones que los comprenden y procesos de preparacion?.
US8367829B2 (en) 2010-05-10 2013-02-05 Gilead Sciences, Inc. Bi-functional pyrazolopyridine compounds
EP2575864A1 (en) 2010-06-04 2013-04-10 Trifoilium ApS Trefoil factors (tff) for the treatment of chronic pulmonary diseases
RU2013115747A (ru) 2010-09-09 2014-10-20 ТРИФОЙЛИУМ АпС Введение антиангиогенных агентов в дыхательные пути
GB201108039D0 (en) 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
EP2721036B1 (en) 2011-06-15 2015-07-22 Takeda GmbH Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds
US20140112945A1 (en) 2011-06-17 2014-04-24 Takeda Gmbh Novel phthalazinone-pyrrolopyrimidinecarboxamide derivatives
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
GB201117619D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
GB201117621D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
KR102109223B1 (ko) 2012-05-29 2020-05-11 패리온 사이언스 인코퍼레이티드 안구 건조 및 다른 점막 질환의 치료를 위한 나트륨 채널 차단제 활성을 보유하는 덴드리머 유사 아미노 아미드
CA2896686A1 (en) 2012-12-17 2014-06-26 Parion Sciences, Inc. 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
BR112015014178A2 (pt) 2012-12-17 2017-07-11 Parion Sciences Inc compostos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil)carbamimidoil) pirazina-2- carboxamida
ES2619954T3 (es) 2012-12-17 2017-06-27 Parion Sciences, Inc. Derivados de cloropiracinocarboxamida útiles para el tratamiento de enfermedades favorecidas por una hidratación mucosa insuficiente
GB201306984D0 (en) 2013-04-17 2013-05-29 Mexichem Amanco Holding Sa Composition
BR112018011266B1 (pt) 2015-12-04 2023-11-21 Mexichem Fluor S.A. De C.V. Composição farmacêutica, recipiente vedado, e, métodos para tratar um paciente que sofre ou é propenso a sofrer de um distúrbio respiratório e para estabilizar uma composição farmacêutica
CA3037080C (en) 2016-09-19 2021-05-18 Mexichem Fluor S.A. De C.V. Stable pharmaceutical compositions comprising indacaterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis)
US10792256B2 (en) 2016-09-19 2020-10-06 Mexichem Fluor S.A. De C.V. Pharmaceutical composition
EP3515432B1 (en) 2016-09-19 2021-08-25 Mexichem Fluor S.A. de C.V. Pharmaceutical composition comprising glycopyrrolate
WO2018069210A1 (en) 2016-10-10 2018-04-19 Takeda Gmbh Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB902590A (en) 1960-03-22 1962-08-01 Allied Chem Production of heptafluoropropane
DE1542076A1 (de) * 1966-04-21 1970-03-26 Colgate Palmolive Co Aerosol-Treibmittel
MX3864E (es) 1975-05-27 1981-08-26 Syntex Corp Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona
US4405598A (en) 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
JPS5325284A (en) * 1976-08-19 1978-03-08 Daikin Ind Ltd Aerosol composition
US4352789A (en) 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
JPS5734174A (en) * 1980-08-11 1982-02-24 Toyo Aerosol Kogyo Kk Powdered aerosol composition
GB8613811D0 (en) * 1986-06-06 1986-07-09 Phares Pharm Res Nv Composition & method
GB8501015D0 (en) * 1985-01-16 1985-02-20 Riker Laboratories Inc Drug
US4778674A (en) * 1986-05-28 1988-10-18 Richardson-Vicks Inc. Dry aerosol foam
WO1988001165A1 (en) 1986-08-11 1988-02-25 Innovata Biomed Limited Pharmaceutical formulations comprising microcapsules
DE3815480A1 (de) 1988-05-06 1989-11-16 Boehringer Ingelheim Kg Synergistische kombinationen und ihre verwendung als therapeutika
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US6013245A (en) * 1995-01-26 2000-01-11 Glaxo Group Limited Aerosol formulation containing beclomethasone dipropionate and 1,1,1,2,3,3,3-heptafluoro-n-propane as propellant
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol

Also Published As

Publication number Publication date
WO1991011495A1 (de) 1991-08-08
PT96634A (pt) 1991-10-31
EP0514415B1 (de) 1998-05-06
HU9202509D0 (en) 1992-10-28
SI9110156A (sl) 1998-04-30
HRP940735B1 (en) 1999-10-31
AU650001B2 (en) 1994-06-09
NO923039L (no) 1992-07-31
CS26491A3 (en) 1991-09-15
NO302419B1 (no) 1998-03-02
JP3497161B2 (ja) 2004-02-16
SI9110156B (sl) 1999-04-30
IL97028A (en) 1994-08-26
HU218784B (hu) 2000-12-28
IE910351A1 (en) 1991-08-14
CA2075058A1 (en) 1991-08-04
YU15691A (sh) 1994-01-20
JPH05504160A (ja) 1993-07-01
HUT62456A (en) 1993-05-28
US6413497B1 (en) 2002-07-02
YU49203B (sh) 2004-09-03
CZ286691B6 (cs) 2000-06-14
FI923490A0 (fi) 1992-08-03
HRP940735A2 (en) 1997-06-30
ATE165863T1 (de) 1998-05-15
FI923490A (fi) 1992-08-03
FI102905B1 (fi) 1999-03-15
NZ236973A (en) 1993-08-26
CA2075058C (en) 2001-03-27
DE4003272A1 (de) 1991-08-08
ES2117964T3 (es) 1998-09-01
FI102905B (fi) 1999-03-15
IL97028A0 (en) 1992-03-29
NO923039D0 (no) 1992-07-31
PT96634B (pt) 1998-07-31
ZA91754B (en) 1992-10-28
HK1010786A1 (en) 1999-06-25
AU7211391A (en) 1991-08-21
IE910350A1 (en) 1991-08-14
EP0514415A1 (de) 1992-11-25
SK280426B6 (sk) 2000-02-14
DE59108979D1 (de) 1998-06-10

Similar Documents

Publication Publication Date Title
DK0514415T3 (da) Drivgasblandinger og deres anvendelse i lægemiddelpræparater
DE59501858D1 (de) Flüssiges kohlendioxid enthaltende treibmittel
ES2189410T3 (es) Formulacion farmaceutica en aerosol.
ES2161872T3 (es) Composiciones de hidrofluorocarbono.
AU4657097A (en) Tropodegradable bromine-containing halocarbon additives to decrease flammability of refrigerents, foam blowing agents, solvents, aerosol propellants, and sterilants
NO902045D0 (no) Fremgangsmaate for fremstilling av stivt polyisocyanatskummed lukkede celler.
ES2062388T3 (es) Refrigerante tricomponente.
CA2148854A1 (en) Near-azeotropic blends for use as refrigerants
DE68912464D1 (de) Rückverflüssigung von verdampftem Flüssigerdgas.
ATE196999T1 (de) Stabile multiple emulsionen
ES2147168T1 (es) Composicion refrigerante.
ATE96836T1 (de) Azeotrope von wasserstoff enthaltenden kohlenstoffen mit butanen.
SG48242A1 (en) Azeotropic or azeotrope-like compositions of pentafluoroethane and propane of isobutane
ES2133546T3 (es) Emulsiones de fluorocarburos con propiedades reducidas de retencion de gas en los pulmones.
DE50305118D1 (de) Hfa-suspensionsformulierungen enthaltend ein anticholinergikum
DK0632090T3 (da) Fremgangsmåde til opskumning af brandhæmmende styrenpolymerisater
Olver Abstractness, imagery, and meaningfulness in recognition and free recall.
NO953675L (no) Azeotrop-lignende blandinger av 1,1,1,2,3,3,3-heptafluor propan og 1,1-difluoretan, og anvendelse av slike
IT1115706B (it) Composizioni propellenti per aerosol
Yorgancıoǧlu et al. An alternative application of sodium nitroprusside to overcome perioperative spasm of the internal thoracic artery
Medina A Historical Reconstruction of the Juramentado/Sabllallah Ritual
Ivanchin Spherical asymmetric solution for point defect
Bernier United States Marine Corps commissioned officers' concerns regarding the United States Marine Corps professional military education program.
IT1277086B1 (it) Composizioni quasi-azeotropiche costituite da fluorocarburi idrogenati e idrocarburi adatte come fluidi propellenti per aerosol